#39: Too Lit to Sleep, Too Hairy to Care, Too Toxic to Breathe

• ❤️ Made-in-India miracle! Surat’s Supraflex Cruz, a new-gen heart stent, wins global acclaim after trials show fewer heart attacks. (ET)

• 🧠 Pill against forgetfulness: A first-of-its-kind Alzheimer’s capsule shows promise by blocking toxic brain proteins and slowing brain shrinkage in those at genetic risk. (MNT)

• ⌚ Gemini joins Fitbit! Google’s AI health coach debuts on Fitbit and Pixel Watch, offering real-time guidance, from doctor visits to menopause. (MobiHealthNews)

• 💡 Too bright, too risky! A study finds night-time light can throw your body clock off, raising heart risk by 50%. Quick fix: turn off screens and dim the lights before sleep. (TOI)

• 💁‍♂️ From bare to hair! Taiwan scientists created a fatty acid serum that regrew hair in 20 days - no surgery, no fuss. Turkey trips? Cancelled. (BS)

• ⚠️ Sniff with caution! Thailand’s FDA flags the popular green Hong Thai inhaler (Lot 000332) sold in Vietnam after tests detected mould and spores that cause respiratory infections. (HT)

• 🚨 Beauty gamble alert! Maharashtra dermatologists warn against untrained hands behind Botox and laser procedures, urging the medical council to act fast. (MedicalDialogues)

🇮🇳 India

• 💨 Delhi’s post-Diwali smog is choking more than lungs; it’s endangering unborn lives. Doctors report a 30% spike in pregnancy complications as toxic air cuts fetal oxygen. (HT; TheHindu)

• ⚖️ Shackled minds, silent rights. The SC has tasked India’s Human Rights Body with enforcing the Mental Health Act after patients were found chained in mental hospitals. (ETHealth)

• 🚗 India’s air crisis turns deadly: The Lancet reports 1.72M deaths in 2022, up 38% since 2010, driven by toxic emissions from coal power and vehicle pollution. (IndiaToday)

• 💸 Tax gone, demand on! Zero GST sparks a 38% surge in health insurance as Indians boost their coverage to an average of ₹18L. (ET)

🌏️ Global

• 🦠 Guess who’s back (again)? Measles resurges in the U.S., while Canada may lose its elimination tag. All driven by falling vaccination rates and fading immunity. (CNN)

• 🇨🇳 China’s $3B biotech bet pushes ethics to the brink, creating monkeys engineered with autism and schizophrenia to decode human disease. (Science.slashdot)

• 💥 Texas takes on Tylenol! The state is suing J&J and Kenvue for allegedly hiding autism and ADHD risks from prenatal use, claims experts call baseless. (StraitsTimes)

• 👩🏻‍⚖️ Skin-deep scandal! Big drugmakers sued in the U.S. for teaming up to fix prices on 80 generic skin drugs under fake “supply issues.” (Reuters)

🇮🇳 India

• ✈️ Narayana Health takes off to the UK, acquiring Practice Plus Group Hospitals for ₹2,200 Cr. (ET)

• 💊 India’s pharmaceutical and healthcare sectors sealed 72 deals worth $3.5B in Q3 2025. The standout? Torrent Pharma’s massive $1.4B acquisition of JB Chemicals. (ET)

• 💨 Cipla’s breathing easy! A record ₹7,500 Cr Q2 FY25 revenue sets up the pharma giant for its next big act, 4 respiratory drug launches lined up for 2026. (ET)

• 🔔 Leadership shake-up at Sanofi India! Global pharma ace Deepak Arora takes charge as Managing Director, armed with 30+ years of cross-continent experience. (ET)

• 🌿 From roots to riches! India’s Ayurveda economy hits $43B, aiming for 5% of GDP by 2047, fueled by $1.2B investments and wellness tourism. (ETHealth)

🌏️ Global

• 🪙 Novo Nordisk flexes its wallet! The Ozempic maker drops a $9B bid for the U.S. biotech Metsera, outbidding Pfizer’s $7.3B offer for next-gen obesity cures. (TOI)

• ⚡ Thermo Fisher’s shopping spree continues as it eyes Clario in a $9.4 billion deal to boost its drug-trial tech.  (Reuters)

📢 Enjoyed this edition?  Forward it to a friend or colleague who’d love to stay informed! They can subscribe here.